← Back to Company DatabaseVisit Website
Nucleo
AI-powered automated cancer diagnostics from CT scans.
Pre-seed / SeedSan Francisco, CAFounded 2025
About
Nucleo is an agentic AI platform for oncology that helps oncologists and radiologists extract insights from CT scans to support tumor characterization and treatment decisions. Its segmentation is 2,500x faster than manual methods with 98% agreement with medical experts. The company partners with Stanford Hospital, Cedars-Sinai, UCI Health, and Weill Cornell.
Total Funding
$4MKey Product
Nucleo automated cancer diagnostics platformGeography
North AmericaKey Investors
Y Combinator
Focus Areas
DiagnosticsAI / Machine Learning
Technology
AI / Machine LearningImaging / Radiology
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026